Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes.
Azuma K, Rádiková Z, Mancino J, Toledo FG, Thomas E, Kangani C, Dalla Man C, Cobelli C, Holst JJ, Deacon CF, He Y, Ligueros-Saylan M, Serra D, Foley JE, Kelley DE.
Azuma K, et al. Among authors: toledo fg.
J Clin Endocrinol Metab. 2008 Feb;93(2):459-64. doi: 10.1210/jc.2007-1369. Epub 2007 Nov 27.
J Clin Endocrinol Metab. 2008.
PMID: 18042650
Clinical Trial.